Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation

Zhu Wang(ShenZhen People’s Hospital), Xu Wu(Southwest Medical University)
Chinese Medicine
March 12, 2019
Cited by 137


Related Papers